Appropriate logistic policies such as stocking of ASV and additional treatment modalities can be formulated, ensuring optimal utilization of health-care resources. is definitely questionable.[1] The current scenario reflects the loss of the crucial golden hour after the bite because of visit to traditional healers, whose part is debatable. Although a plethora of medicinal plants have shown activity against numerous manifestations, there is no recorded, proven, or validated data of potent preparations and molecules.[2] In the health-care facility, there is poor compliance with the already-drafted protocols coupled with little encounter and confidence of the treating physicians. Availability, affordability, and rational use of ASV is an important issue. You will find multiple problems associated with venom and ASV. The composition of snake venom, varies considerably with species, exhibiting a assorted range of pharmacological properties. In India, around 80% of venom from Big Four is definitely procured from two districts in Tamil Nadu. In fact, there is scarce supply of quality venom from reliable dealers. Wide geographical intra- and inter-species variance in the immunogenicity of the venom, leading to different constellation of symptoms, is definitely a matter of concern.[1] There are numerous logistical, marketing, and economic issues with the production and supply of ASV, besides the accompanying side effects. About seven laboratories in India create polyvalent ASV raised against the traditional Big Four. However, the actual production statistics is PTGIS not known. One of the important limitations of ASV is definitely its high production cost. The varied issues related to snake bites warrant a multipronged approach revolving mainly around improved recommendations addressing diversity, standard management protocols, preventive steps, and study in venomics and antivenomics. The strategy for point-of-care management stresses within the immobilization of victim and early administration of ASV.[3] Development of snake farms across numerous unique regions in India and collection from a wide geographical regional array, keeping in view the comprehensive details about intra- and inter-species variability, and creating regional venom swimming pools are needed. To achieve the goal of less morbidity and mortality, study in venomics, antivenomics, and toxicovenomics is the top priority.[4] Contemporary research should focus on unmasking the complete antigenic profile of venoms from important and taxonomically undetermined genera from different geographical locations. Detailed exploration into venom composition directly by proteomics or indirectly via high-throughput venom gland transcriptomics and bioinformatics is definitely of vital importance. Efforts should be directed toward the use of recombinant antibody systems.[5] The geographical diversity necessitates the development of affordable, broad-range, polyvalent ASV with high potency, covering some regional medically relevant species. Optimization of the dose schedule can tackle the issue of short supply and also the probability of life-threatening adverse effects. Well-drafted standard immunization protocol and improvement of security profile by quality control need to be guaranteed. An alternative to polyvalent form is definitely monovalent ASV, but its power Ciproxifan is restricted and may not become economically viable inside a country like India. The search for numerous potential inhibitors from flower sources that can adjunct or substitute the ASV activity Ciproxifan should continue. Specific, regional ethnobotanical studies along with the development of a database of vegetation with antisnake potential would be useful. The socioeconomic effect of snake bite is definitely profound as many victims may end Ciproxifan up with long term physical and mental sequelae. Various state governments in India are providing payment to victims or the families of the lifeless and the same should be considered by claims with high incidence. An important requisite is definitely to create consciousness and sensitization of rural populations and medical and paramedical staff by educational and preventive campaigns, highlighting the locally common snakes, early manifestations, appropriate first-aid steps, and importance of appropriate medical management. The current spread Ciproxifan data in India does not highlight a realistic view of the magnitude of the problem of snake bite. To facilitate appropriate management, a mobile phone-enabled, web-based info system may be developed and validated along with info, education and communication activities. It will help 1st responders to take informed decisions within the short possible time and enhance community consciousness and participation, besides acting like a national registry of snake bite instances. Appropriate logistic guidelines such as stocking of ASV and additional treatment modalities can be formulated, ensuring Ciproxifan optimal utilization of health-care resources. Coordinated attempts at regional and national levels can help to reduce the effect of the problem and hence the astounding death count. Financial support and sponsorshipNil. Conflicts of interest You will find no conflicts of interest..